三支血管血流储备分数测量在冠心病患者中的临床意义
本研究基于3V FFR-FRIENDS研究(NCT01621438)的1136例冠心病患者,评估三支血管FFR总和(3V-FFR)所反映的总体生理性动脉粥样硬化负荷的预后价值。按3V-FFR中位数2.72分为高、低两组,主要终点为2年主要不良心脏事件(MACE)。低3V-FFR组2年MACE风险显著高于高3V-FFR组(7.1% vs. 3.8%,HR 2.205,95%CI 1.201-4.048,P=0.011),且低3V-FFR是多变量校正后MACE的独立预测因子(HR 2.031,95%CI 1.078-3.830,P=0.029)。
要点
- 3V-FFR与2年MACE率呈负相关(P<0.001)。
- 低3V-FFR组2年MACE风险更高(7.1% vs. 3.8%,HR 2.205)。
- 低3V-FFR是多变量校正后MACE的独立预测因子(HR 2.031)。
核心结论
- 3V-FFR评估的总体生理性动脉粥样硬化负荷高的患者,2年临床事件风险高于负荷低的患者。
- 差异主要由基线功能显著和不显著病变的缺血驱动血运重建驱动。
- 三支血管FFR可作为冠心病患者的预后指标。
研究设计与样本
- 研究为3V FFR-FRIENDS研究(NCT01621438),共纳入1136例接受三支血管FFR测量的患者。
- 按3V-FFR中位数2.72分为高3V-FFR组和低3V-FFR组。
- 主要终点为2年主要不良心脏事件(MACE,包括心源性死亡、心肌梗死和缺血驱动血运重建)。
主要发现
- 平均造影直径狭窄百分比为43.7 ± 19.3%,平均FFR为0.90 ± 0.08。
- 3V-FFR与估计2年MACE率呈负相关(P < 0.001)。
- 低3V-FFR组2年MACE风险高于高3V-FFR组(7.1% vs. 3.8%,HR 2.205,95%CI 1.201-4.048,P = 0.011)。
- 低3V-FFR组缺血驱动血运重建率更高(6.2% vs. 2.7%,HR 2.568,95%CI 1.283-5.140,P = 0.008)。
- 多变量校正模型中,低3V-FFR是MACE的独立预测因子(HR 2.031,95%CI 1.078-3.830,P = 0.029)。
临床怎么用
- 三支血管FFR测量可用于评估冠心病患者总体生理性动脉粥样硬化负荷。
- 低3V-FFR(≤2.72)提示2年MACE风险较高,可考虑作为预后指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: There are limited data on the clinical implications of total physiologic atherosclerotic burden assessed by invasive physiologic studies in patients with coronary artery disease. We investigated the prognostic implications of total physiologic atherosclerotic burden assessed by total sum of fractional flow reserve (FFR) in three vessels (3V-FFR). METHODS AND RESULTS: A total of 1136 patients underwent FFR measurement in three vessels (3V FFR-FRIENDS study, NCT01621438). The patients were classified into high and low 3V-FFR groups according to the median value of 3V-FFR (2.72). The primary endpoint was major adverse cardiac events (MACE, a composite of cardiac death, myocardial infarction and ischaemia-driven revascularization) at 2 years. Mean angiographic percent diameter stenosis and FFR were 43.7 ± 19.3% and 0.90 ± 0.08, respectively. There was a negative correlation between 3V-FFR and estimated 2-year MACE rate (P < 0.001). The patients in low 3V-FFR group showed a higher risk of 2-year MACE than those in the high 3V-FFR group [(7.1% vs. 3.8%, hazard ratio (HR) 2.205, 95% confidence interval (CI) 1.201-4.048, P = 0.011]. The higher 2-year MACE rate was mainly driven by the higher rate of ischaemia-driven revascularization in the low 3V-FFR group (6.2% vs. 2.7%, HR 2.568, 95% CI 1.283-5.140, P = 0.008). In a multivariable adjusted model, low 3V-FFR was an independent predictor of MACE (HR 2.031, 95% CI 1.078-3.830, P = 0.029). CONCLUSION: Patients with high total physiologic atherosclerotic burden assessed by 3V-FFR showed higher risk of 2-year clinical events than those with low total physiologic atherosclerotic burden. The difference was mainly driven by ischaemia-driven revascularization for both functionally significant and insignificant lesions at baseline. Three-vessel FFR might be used as a prognostic indicator in patients with coronary artery disease. CLINICAL TRIAL REGISTRATION: 3V FFR-FRIENDS study (https://clinicaltrials.gov/ct2/show/NCT01621438, NCT01621438).
引用
- Lee JM, Koo BK, Shin ES, et al. Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery disease. Eur Heart J. 2018. PMID: 29020260. doi:10.1093/eurheartj/ehx458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。